Context The relative importance of the control of different metabolic risk factors for the
prevention of chronic kidney disease among patients with diabetes in real life conditions is …

Aims Non-HDL cholesterol represents the pro-atherogenic, apo-B-containing lipoprotein
fraction of circulating lipids, and represents a secondary target for CVD prevention in people …

Background Chronic kidney disease (CKD) entails a worse cardiovascular outcome. The
aim of our work was to study the relationship between CKD and the achievement of …

Background We investigated cross-sectional and prospective associations of ABC
(hemoglobin A1c (HbA1c), blood pressure and low-density lipoprotein cholesterol) goal …

The prevalence of chronic kidney disease and diabetes is rising in Europe. These patients
are at high cardiovascular and renal risk and need a challenging multifactorial therapeutic …

Rationale & Objective Few studies have examined incident type 2 diabetes mellitus (T2DM)
in chronic kidney disease (CKD). Our objective was to examine rates of and risk factors for …

Background. Variability in chronic kidney disease (CKD) progression is a well‐known
phenomenon that underlines the importance of characterizing the said outcome in specific …

Studies on the effects of longitudinal lipid trajectories on end-stage renal disease (ESRD)
development and deaths among patients with chronic kidney disease (CKD) are limited. We …

Background: The two major causes of CKD are type 2 diabetes (T2D) & hypertension, which
are responsible for up to two-thirds of the cases. More than half of patients in Mexico with …

Background Achieving an optimal glycemic control has been described to reduce the
incidence of diabetes mellitus (DM) related complications. The association between …